Villani Medical

Villani Medical is a clinical-stage biotechnology company focused on developing innovative dermatological treatments, primarily for acne vulgaris. The company's core technology utilizes a proprietary micro-biomass derived from freshwater sponges, which creates temporary micro-channels in the skin to enhance the delivery of therapeutic agents. This non-invasive approach aims to provide the efficacy of professional-grade treatments with the convenience of a topical application. Villani Medical is currently advancing its lead candidate, V-01, through clinical trials to establish safety and efficacy in patients with moderate-to-severe acne. The platform has the potential to be expanded to other dermatological indications requiring targeted topical delivery.